HTA9 A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy
Abstract
Authors
Ronald Schwarz Ágnes Benedict Pal Rakonczai Balazs Dobi Necdet B. Gunsoy Virginie Lavaud